Moody Aldrich Partners’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-55,615
Closed -$1.67M – 187
2025
Q3
$1.67M Sell
55,615
-11,304
-17% -$319K 0.32% 106
2025
Q2
$1.91M Sell
66,919
-14,315
-18% -$426K 0.37% 94
2025
Q1
$2.68M Sell
81,234
-1,239
-2% -$40.4K 0.56% 69
2024
Q4
$2.37M Sell
82,473
-2,434
-3% -$70K 0.44% 88
2024
Q3
$2.38M Buy
84,907
+22,841
+37% +$609K 0.43% 89
2024
Q2
$1.5M Sell
62,066
-4,142
-6% -$102K 0.29% 107
2024
Q1
$1.79M Buy
66,208
+13,638
+26% +$387K 0.3% 106
2023
Q4
$1.46M Buy
52,570
+12,496
+31% +$325K 0.26% 108
2023
Q3
$1.12M Buy
+40,074
New +$1.17M 0.21% 115

Other funds holding ALKS

Moody Aldrich Partners's ALKS Position: Q4 2025 in Review

Moody Aldrich Partners sold out of Alkermes (ALKS) in Q4 2025, closing a stake of 55,615 shares — an estimated $1.67M sold.

Moody Aldrich Partners first reported a position in ALKS in Q3 2023 and held it in 9 quarters. The position peaked at $2.68M in Q1 2025. 366 funds tracked by Wall St. Rank hold ALKS as of Q4 2025.

  • Moody Aldrich Partners reported no remaining Alkermes position as of Q4 2025 after selling out during the quarter.
  • Moody Aldrich Partners sold 55,615 Alkermes shares in Q4 2025, an estimated $1.67M.
  • Moody Aldrich Partners first reported a position in Alkermes in Q3 2023 and held it in 9 quarters.
  • Moody Aldrich Partners's Alkermes position peaked at $2.68M in Q1 2025.
  • 366 funds tracked by Wall St. Rank held Alkermes as of Q4 2025.

Based on Moody Aldrich Partners's 13F filing for Q4 2025, filed 30 Jan 2026.